Literature DB >> 20060141

Current concepts in triglyceride metabolism, pathophysiology, and treatment.

Georges AbouRjaili1, Norbert Shtaynberg, Robert Wetz, Thomas Costantino, George S Abela.   

Abstract

It is becoming more evident that age, gender, and race play a significant role in the metabolic profiles that are seen among individuals in a clinical setting. It is important to understand these variances in metabolic profiles; and with these variances in mind it is now possible to understand why a single diet might not decrease cardiovascular disease risk profiles uniformly for everyone. Much is now understood about triglyceride metabolism and its contribution to energy storage. In this review we will focus on triglycerides; their production, metabolism and influence on daily life, as well as the various methods for the treatment of hypertryglyceridemia and prevention of its sequelae. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20060141     DOI： 10.1016/j.metabol.2009.11.014

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


  14 in total

1.  Advancing age is associated with gene expression changes resembling mTOR inhibition: evidence from two human populations.

Authors:  Lorna W Harries; Alexander D Fellows; Luke C Pilling; Dena Hernandez; Andrew Singleton; Stefania Bandinelli; Jack Guralnik; Jonathan Powell; Luigi Ferrucci; David Melzer
Journal:  Mech Ageing Dev       Date:  2012-07-16       Impact factor: 5.432

Review 2.  Lipid Use and Misuse by the Heart.

Authors:  P Christian Schulze; Konstantinos Drosatos; Ira J Goldberg
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

3.  A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative.

Authors:  Marian L Neuhouser; Barbara Howard; Jingmin Lu; Lesley F Tinker; Linda Van Horn; Bette Caan; Thomas Rohan; Marcia L Stefanick; Cynthia A Thomson
Journal:  Metabolism       Date:  2012-05-26       Impact factor: 8.694

4.  Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humans.

Authors:  Leigh Perreault; Bryan C Bergman; Devon M Hunerdosse; David J Howard; Robert H Eckel
Journal:  Metabolism       Date:  2011-02-08       Impact factor: 8.694

5.  Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.

Authors:  Yunpeng Guan; Xiaoyu Hou; Peipei Tian; Luping Ren; Yong Tang; An Song; Jiajun Zhao; Ling Gao; Guangyao Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

6.  The relationship among adiponectin, high sensitive C reactive protein and triacylglycerol level in healthy young persons.

Authors:  Juxiang Li; Chenghong Liao; Hai Su; Qiang Peng; Zhihong Zhang; Sujian Yan; Qing Yang
Journal:  Lipids Health Dis       Date:  2011-06-30       Impact factor: 3.876

7.  Association between adherence to nutritional guidelines, the metabolic syndrome and adiposity markers in a French adult general population.

Authors:  Camille Lassale; Pilar Galan; Chantal Julia; Leopold Fezeu; Serge Hercberg; Emmanuelle Kesse-Guyot
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  Endoplasmic Reticulum Stress Inducer Tunicamycin Alters Hepatic Energy Homeostasis in Mice.

Authors:  Bin Feng; Xiaohua Huang; Dandan Jiang; Lun Hua; Yong Zhuo
Journal:  Int J Mol Sci       Date:  2017-08-04       Impact factor: 5.923

9.  Prediction of Blood Lipid Phenotypes Using Obesity-Related Genetic Polymorphisms and Lifestyle Data in Subjects with Excessive Body Weight.

Authors:  Omar Ramos-Lopez; Jose I Riezu-Boj; Fermin I Milagro; Marta Cuervo; Leticia Goni; J A Martinez
Journal:  Int J Genomics       Date:  2018-11-19       Impact factor: 2.326

10.  Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity.

Authors:  L Xiao; X Yang; Y Lin; S Li; J Jiang; S Qian; Q Tang; R He; X Li
Journal:  Int J Obes (Lond)       Date:  2013-08-07       Impact factor: 5.095
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.